Clinical Trials · NCT05891587
Semaglutide Therapy for Alcohol Reduction - Tulsa
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Oklahoma State University Center for Health Sciences
- Enrollment
- 80
- Start date
- Jul 2023
- Locations
- 1 site, United States
- Primary endpoint
- Change in alcohol drinks per drinking day.